Target intelligence / Profile preview

Nuclear pore complex protein Nup153 (NUP153)

Target
NUP153
Molecular classification
Nucleoporin (nuclear pore complex protein)[2][7], Other (does not fit into classical families such as receptor, enzyme, transporter)
01

Overview

Nuclear pore complex protein Nup153 (NUP153) is an essential nucleoporin located in the basket structure on the nuclear side of the nuclear pore complex in vertebrates[2]. It serves as an anchoring point for the nuclear pore, acts as a docking site for karyopherins (transport proteins), and contains three main regions: an N-terminal pore targeting and RNA-binding domain, a central region with zinc finger motifs (Ran-GDP binding), and a C-terminal region with XFXFG repeats for receptor docking and Lamin B binding[4][7]. NUP153 plays key roles in the regulation of nucleocytoplasmic transport, chromatin architecture (by interacting with CTCF and cohesin[1]), cell cycle regulation (mitotic progression and nuclear structure[3]), and export of multiple cargo classes including RNA and proteins such as the HIV Rev protein[5]. It also facilitates efficient transcriptional responses for developmental genes and participates in DNA damage response by promoting import of 53BP1[6]. Its loss disrupts nuclear pore assembly, mitotic checkpoint regulation, and proper RNA/protein export, contributing to various disease states, chiefly cancer and restrictive dermopathy[7][1][5]. There are no drugs directly targeting NUP153, and its essential cellular role means that safety concerns preclude its use as a pharmacological target.

Other names
Nup153HNUP153N153153 kDa nucleoporinNucleoporin 153kDaNuclear pore complex protein hnup153Nucleoporin Nup153NUP153
02

Mechanism of action

None established for drugs, as NUP153 is not a classical drug target. Some RNAs, proteins (e.g., HIV Rev), and nuclear transport modulators functionally interact with NUP153 by binding or relying on its export or import activity, but no drug directly targets it[5].

03

Biological functions

Nucleocytoplasmic transport (facilitates regulated movement of macromolecules between nucleus and cytoplasm)[2][5][7]Chromatin architecture regulation (links nuclear pore complex to chromatin via binding with CTCF and cohesin)[1]Cell cycle regulation (important for proper mitotic progression; Tpr and Mad1/Mad2 checkpoint interaction)[3]RNA export (critical for snRNA, mRNA, and 5S rRNA export, along with NES protein export)[5]Nuclear structure and NPC assembly (anchors the nuclear pore complex and basket structure)[2][4]DNA damage response (promotes nuclear import of 53BP1 in double-strand break repair)[6]Transcriptional regulation (affects chromatin organization at cis-regulatory elements, influences Pol II pausing)[1][4]
04

Disease associations

Cancer (altered nucleocytoplasmic transport and chromatin organization implicated in oncogenesis)[1][7]Neuromuscular and skin disorders (associated with restrictive dermopathy)[7]Metabolic disorder (linked to Carnitine-acylcarnitine translocase deficiency[7])Other (possibly involved in defective mitosis and genomic instability, but not a primary disease driver)
05

Safety considerations

As an essential nuclear pore component, alteration or inhibition of NUP153 functions would disrupt nucleocytoplasmic transport and mitosis, likely resulting in cell death or severe dysfunction, making it unsuitable as a therapeutic target[5][3].
06

Biomarkers

NUP153 expression or localization could theoretically be used as a biomarker for nuclear envelope integrity, nuclear transport activity, or certain chromatin architecture changes, but is not an established clinical biomarker[1].

Beyond the preview

Go deeper on Nuclear pore complex protein Nup153 (NUP153).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuclear pore complex protein Nup153 (NUP153).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call